Selenium: An important component of sepsis therapy?

British Journal of Intensive Care

Volumn 15, Issue 1, 2005, Pages 28-36

  Hardy, Gil ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYTOKINE; FREE RADICAL; INTERLEUKIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; REACTIVE OXYGEN METABOLITE; SELENIUM; SODIUM SELENITE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; ANTIOXIDANT ACTIVITY; BURN; CHILD; CONTROLLED STUDY; CRITICAL ILLNESS; DIET SUPPLEMENTATION; HUMAN; IMMUNE RESPONSE; INFECTION; MAJOR CLINICAL STUDY; MULTIPLE TRAUMA; PARENTERAL NUTRITION; PRACTICE GUIDELINE; REVIEW; SELENIUM DEFICIENCY; SEPSIS; SEPTIC SHOCK;

EID: 17644387623     PISSN: 09617930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Hardy G. Does glutamine enable severely ill intensive care patients to cope better with infection and increase their chance of survival? Nutrition 2002; 18: 712-714.
2. Chow WJ, Fine MJ, Shlaes DM et al. Enterobacter bacteraemia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-590.
3. Mackenzie S. The epidemiology of sepsis in UK intensive care. Care of the Critically Ill 2002; 18: 102-103.
4. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004, 30: 589-596.
5. Stephen M, Lowenthal J. Continuing peritoneal lavage in high risk peritonitis. Surgery 1979; 85: 603-606.
6. Altemeier WA, Culbertson WR, Fullen WD et al. Intra abdominal abscesses. Am J Surg 1973; 125: 70-79.
7. Costings LG, Speelman P, van Lieshout JJ et al. Immunotherapy using anti-endotoxin antibody HER-1A (Centoxin) in patients with sepsis syndrome; fair results following protocol selection of patients. Ned Tijdschr Geneeskd 1993; 137: 355-360.
8. Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma: a prospective randomized study. J Trauma 1986; 26: 874-880.
9. Ledingham IM, Alcock SR, Eastaway AT, McDonald JC, McKay IC, Ramsay G. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1988; 336: 785-790.
10. Unertl K, Ruckdeschel G, Selbmann HK et al. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987; 173: 240-241.
11. Hardy G, Hardy IJ. Selenium: The Se-XY Nutraceutical. Nutrition 2004; 20: 590-593.
12. Bender DA. Daily doses of multivitamin tablets. BMJ 2002; 325: 173-174.
13. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992; 340: 1124-1127.
14. Bogden JD, Bendich A, Kemp FW et al. Daily micronutrient supplements enhance delayed hypersensitivity skin response in older people. Am J Clin Nutr 1994; 60: 437-447.
15. Berger MM, Cavadini C, Bart A et al. Selenium losses in 10 burned patients. Clin Nutr 1992; 11: 75-82.
16. Berger MM, Shenkin A, Revelly JP. Copper, selenium, zinc, and thiamine balances during continuous venevenous hemofiltration in critically ill patients. Am J Clin Nutr 2004; 80: 410-416.
17. Angstwurm MWA, Schottdorf J, Schophol J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Critical Care Med 1999; 27: 1807-1813.
18. Vitoux D, Forceville X, Gauzit R, Lahilaire P, Combes A, Chappius P. Low plasma selenium in patients admitted in an intensive care unit is related to systemic inflammatory response syndrome and sepsis. Therapeutic use of trace elements. New York, USA: Plenum Press, 1996.
19. Dimitrov NV, Charamella LJ, Meyer CJ, Stowe HD, Ku PK, Ullrey DE. Modulation of natural killer cell activity by selenium in humans. J Nutr Growth Canc 1986; 3: 193-198.
20. Rayman MP. Dietary selenium: time to act. BMJ 1997; 314: 387-388.
21. Wendel A. Glutathione peroxidase. In: Jakoby WB, Bend JR, Caldwell J (eds). Enzymatic Basis of Detoxification. New York, USA: Academic Press, 1980.
22. Nathan CF, Arrick BA, Murray HW et al. Tumour cell antioxidant defences. J Experiment Med 1980; 153: 766-782.
23. Keller GA, Barke R, Harty JT, Humphrey E, Simmons RL. Decreased hepatic glutathione levels in septic shock. Arch Surg 1985; 120: 941-945.
24. Ping Z, Boom SJ, Davidson JAH, Ramsay G. Effects of partial hepatic ischaemia and reperfusion on organ metabolism and leukocyte activity. Clin Intensive Care 1992; 3: 31S.
25. Oliver J, Albertinin DF, Berlin RD. Effects of glutathione-oxidizing agents on microtubular assembly and microtubule-dependent surface properties of human neutrophils. J Cell Biol 1976; 75: 921-923.
26. Beck MA, Kolbeck PC, Shi Q, Rohr LH, Morris VC, Levander OA. Increased virulence of a human enterovirus (Coxsackie B3) in selenium deficient mice. J Infect Dis 1994; 170: 351-357.
27. Markolpoulos V, Bruning T, Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-kappa B and HIV1 LTR promoter activity. Arch Toxicol 1996; 70: 277-283.
28. Yu SZ, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Element Res 1997; 56: 117-124.
29. Anneren G, Magnusson CG, Nordvall SL. Increase in serum concentration of Ig2 and Ig4 by selenium suplementation in children with Down's syndrome. Arch Dis Child 1990; 65: 1353-1355.
30. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Selenium supplementation enhances the expression of interleukin 2 receptor subunits and internalization of interleukin 2. Proc Soc Exp Biol Med 1993; 202: 295-301.
31. Shenkin A. Micronutrients and antioxidants in home parenteral nutrition. Clin Nutr 2001; 20 (Suppl. 2): 47-50.
32. King J. The need to consider functional endpoints in defining nutrient requirements. Am J Clin Nutr 1996; 63: S983-984.
33. Windisch W, Gabler S, Kirchgessner M. Effect of selenite, selenocysteine and selenomethionine on the selenium metabolism of 75Se labeled rats. J Anim Physiol Anim Nutr 1997; 78: 67-74.
34. Berger MM, Chiolero R. Relations between copper zinc and selenium intakes and malondialdehyde excretion after major burns. Burns 1995; 21: 507-512.
35. Berger MM, Shenkin A. Role of trace elements and other antioxidants in the dritically ill. Care of the Critically Ill 2003; 19: 120-125.
36. Berger MM, Berger-Gryllaki M, Wiesel PH, Hurni M, Revelly JP, Tappy L et al. Gastrointestinal absorption after cardiac surgery. Crit Care Med 2000; 28: 2217-2223.
37. Berger M, Spertini F, Baines M et al. Trace element supplements have pharmacological effects and reduce infectious complications in burns - a randomized trial. Clin Nutr 1997; 16: 2.
38. Berger MM, Spertini F, Shenkin A et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo controlled trial. Am J Clin Nutr 1998; 68: 365-371.
39. Porter JM, Ivatury PR, Azimuddin K, Swami R. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: Early results of a prospective randomized study. Am J Surg 1999; 65: 478-483.
40. Berger MM, Baines M, Wardle CC et al. Influence of early trace element and vitamin E supplements on the plasma antioxidant status after major trauma: a controlled trial. Nutritional Research 2001; 21: 41-54.
41. Bowrey DJ, Morris-Stiff GJ, Puntis MC. Selenium deficiency and chronic pancreatitis: disease mechanism and potential for therapy. HPB Surgery 1999; 11: 207-215.
42. Bhardwaj P, Thareja S, Prakash S, Saraya A. Micronutrient intake in patients with chronic pancreatitis. Topical Gastroenterology 2004; 25: 69-72.
43. Birk D, Schoenberg MH, Eisele S, Rau B, Berger HG. Die Bedeutung der Sauerstoffradikale bei akuter Pankreatitis. Klinische und experimentelle Ergebnisse der Radikalfängertherapie. Med Klin 1995; 90 (Suppl 1): 32-35.
44. Schilling JU, Zimmermann T, Albrecht S. Selentherapie bei akuter Pankreatitis: Ein historischer Überblick vor (1986-1991) und nach (1991-1996) Einführung der Selentherapie. Vortrag auf dem III Dresdener Selen - Symposium 24-25. May 1997, Dresden
45. McNamee D, McCarthy G, Sheridan M. Micronutrients in intensive care. Brit J Intensive Care 1999; 9: 6-8.
46. Berger M, Cavadini C, Chiolero R, Dirren H. Copper, selenium and zinc status and balances after major trauma. J Trauma 1996; 40: 103-109.
47. Angstwurm MW, Schopohl J, Gärtner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol 2004; 151: 47-54.
48. Gärtner R. Natriumselenit als adjunctive Therapie bei Sepsis - klinische Daten einer Multicenterstudie. DIVI Symposium 'Adjunktive Therapie der Sepsis: Was ist gesichert?' Hamburg, Germany 1-4 Dezember 2004.
49. Hardy G, Reilly C. Technical aspects of trace element supplementation. Curr Opin Clin Nutr Metab Care 1999; 2: 277-285.
50. Sill-Steffens R, Hardy G. Sodium selenite stability in intravenous solutions. Clin Nutr 2004; 23: 827.
51. Duffield A, Thomson CD, Hill K et al. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999; 70: 896-903.
52. Food and Nutrition Board, Institute of Medicine. DRI: dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. Washington DC, USA: National Academy Press, 2000.
53. st international Sepsis Congress Weimar, 2003.